Home Overview Press Room Blog Publications For Students about us
Search

Genetic Selection : Displaying 11-20 of 555


As Chinaís one-child policy ends, surrogacy services rise in the U.S.by Kevin SmithSan Gabriel Valley TribuneApril 30th, 2016ďIíve been contacted by 15 to 18 agencies out of China... 90 percent of them donít have any patients. Theyíre just new agencies trying to make a buck."
With CRISPR in Humans On the Horizon, Will the Public Back Intellia?by Alex LashXconomyApril 29th, 2016Intellia and Editas both lack what so many biotech investors crave: data from human clinical trials. As they race to the clinic, it's hard to tell if either company will pay off.
Let people most affected by gene editing write CRISPR rulesby Jessica HamzelouNew ScientistApril 29th, 2016The US National Academies' committee on human gene editing held a discussion in Paris at the French National Academy of Medicine.
Meet The New CEO Of The $22 Billion Genomics Company You've Never Heard Ofby Christine FarrFast CompanyApril 27th, 2016Gene-sequencing giant Illumina is expanding to direct-to-consumer tests and perhaps brand partnerships, says new CEO Francis deSouza.
Editorial: Editing human genes the CRISPR wayby Editorial BoardThe Chicago TribuneApril 27th, 2016Can we trust scientists and governments to set ethical boundaries for research and therapeutic use ó and then stick to them? We're skeptical.
Godís Red Pencil? CRISPR and The Three Myths of Precise Genome Editingby Jonathan LathamIndependent Science NewsApril 25th, 2016CRISPR is the latest platform in a 70-year-old "gospel of precision" used to justify moving quickly with new chemical and biological technologies, despite decades of disasters and unintended consequences.
US moves to sell gene-edited mushrooms fuel doubts over British ban on GM importsby Robin McKieThe Guardian April 23rd, 2016The USDA approved CRISPR-modified crops, but a European regulatory committee's delays are dismaying some UK researchers.
AstraZeneca launches project to sequence 2 million genomesby Heidi LedfordNature NewsApril 22nd, 2016One of the world's largest pharmaceutical companies is partnering with the Wellcome Trust Sanger Institute and Craig Venter's Human Longevity to look for rare genetic differences between individuals.
Save the Mosquitosby Ashley DawsonJacobinApril 22nd, 2016We should fight Zika with better public health, not genetically modified mosquitos.
We Still Havenít Found a Fountain of Youth in Our DNAby Brian AlexanderMIT Technology ReviewApril 21st, 2016The Cypher Genomics project has been attempting to identify genetic variants that contribute to longevity, but so far there's no smoking gun.
Displaying 11-20 of 555  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760